Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Influenza

  Free Subscription


Articles published in J Virol

Retrieve available abstracts of 248 articles:
HTML format
Text format



Single Articles


    June 2017
  1. PHIPPS KL, Marshall N, Tao H, Danzy S, et al
    Seasonal H3N2 and 2009 pandemic H1N1 influenza A viruses reassort efficiently but produce attenuated progeny.
    J Virol. 2017 Jun 21. pii: JVI.00830-17. doi: 10.1128/JVI.00830.
    PubMed     Text format     Abstract available


  2. CLARK AM, Nogales A, Martinez-Sobrido L, Topham DJ, et al
    Functional evolution of influenza NS1 protein in currently circulating human 2009 pandemic H1N1 viruses.
    J Virol. 2017 Jun 21. pii: JVI.00721-17. doi: 10.1128/JVI.00721.
    PubMed     Text format     Abstract available


  3. NOGALES A, Rodriguez L, DeDiego ML, Topham DJ, et al
    Interplay of PA-X and NS1 proteins in replication and pathogenesis of a temperature-sensitive 2009 pandemic H1N1 influenza A virus.
    J Virol. 2017 Jun 21. pii: JVI.00720-17. doi: 10.1128/JVI.00720.
    PubMed     Text format     Abstract available


  4. NILSSON BE, Te Velthuis AJW, Fodor E
    Erratum for Nilsson et al., "Role of the PB2 627 Domain in Influenza A Virus Polymerase Function".
    J Virol. 2017;91.
    PubMed     Text format    


  5. MAGNEN M, Gueugnon F, Guillon A, Baranek T, et al
    Kallikrein-related peptidase 5 contributes to H3N2 influenza virus infection in human lungs.
    J Virol. 2017 Jun 14. pii: JVI.00421-17. doi: 10.1128/JVI.00421.
    PubMed     Text format     Abstract available


    May 2017
  6. PEREIRA CF, Read EKC, Wise HM, Amorim MJ, et al
    The influenza A virus NS1 protein promotes efficient nuclear export of unspliced viral M1 mRNA.
    J Virol. 2017 May 17. pii: JVI.00528-17. doi: 10.1128/JVI.00528.
    PubMed     Text format     Abstract available


  7. BELSER JA, Pulit-Penaloza JA, Sun X, Brock N, et al
    A novel A(H7N2) influenza virus isolated from a veterinarian caring for cats in a New York City animal shelter causes mild disease and transmits poorly in the ferret model.
    J Virol. 2017 May 17. pii: JVI.00672-17. doi: 10.1128/JVI.00672.
    PubMed     Text format     Abstract available


  8. BOONNAK K, Matsuoka Y, Wang W, Suguitan AL Jr, et al
    Development of clade-specific and broadly reactive live attenuated influenza virus vaccines against rapidly evolving H5 subtype viruses.
    J Virol. 2017 May 10. pii: JVI.00547-17. doi: 10.1128/JVI.00547.
    PubMed     Text format     Abstract available


  9. FUCHS J, Holzer M, Schilling M, Patzina C, et al
    Evolution and antiviral specificity of interferon-induced Mx proteins of bats against Ebola-, Influenza-, and other RNA viruses.
    J Virol. 2017 May 10. pii: JVI.00361-17. doi: 10.1128/JVI.00361.
    PubMed     Text format     Abstract available


  10. WU Y, Wang J, Fan S, Chen R, et al
    Structural Definition of Duck MHC class I Molecules that might explain efficient CTL Immunity against Influenza A Virus.
    J Virol. 2017 May 10. pii: JVI.02511-16. doi: 10.1128/JVI.02511.
    PubMed     Text format     Abstract available


  11. PEACOCK TP, Benton DJ, James J, Sadeyen JR, et al
    Immune escape variants of H9N2 influenza viruses containing deletions at the haemagglutinin receptor binding site retain fitness in vivo and display enhanced zoonotic characteristics.
    J Virol. 2017 May 3. pii: JVI.00218-17. doi: 10.1128/JVI.00218.
    PubMed     Text format     Abstract available


  12. SOBEL LEONARD A, Weissman D, Greenbaum B, Ghedin E, et al
    Transmission Bottleneck Size Estimation from Pathogen Deep-Sequencing Data, with an Application to Human Influenza A Virus.
    J Virol. 2017 May 3. pii: JVI.00171-17. doi: 10.1128/JVI.00171.
    PubMed     Text format     Abstract available


  13. GUEDAN A, Swieboda D, Charles M, Toussaint M, et al
    Investigation of the Role of Protein Kinase D in Human Rhinovirus Replication.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


    April 2017
  14. IVINSON K, Deliyannis G, McNabb L, Grollo L, et al
    Salivary blockade protects the lower respiratory tract of mice from lethal influenza.
    J Virol. 2017 Apr 26. pii: JVI.00624-17. doi: 10.1128/JVI.00624.
    PubMed     Text format     Abstract available


  15. GILBERTSON B, Ng WC, Crawford S, McKimm-Breschkin JL, et al
    Mouse saliva inhibits transit of influenza virus to the lower respiratory tract by efficiently blocking influenza neuraminidase activity.
    J Virol. 2017 Apr 26. pii: JVI.00145-17. doi: 10.1128/JVI.00145.
    PubMed     Text format     Abstract available


  16. WATTERS K, Inankur B, Gardiner JC, Warrick J, et al
    Differential Disruption of Nucleocytoplasmic Trafficking Pathways by Rhinovirus 2A Proteases.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


  17. TZARUM N, McBride R, Nycholat CM, Paulson JC, et al
    Unique structural features of influenza H15 HA.
    J Virol. 2017 Apr 12. pii: JVI.00046-17. doi: 10.1128/JVI.00046.
    PubMed     Text format     Abstract available


  18. SHIN D, Lee J, Park JH, Min JY, et al
    Double PHD Fingers 2 (DPF2) Promotes the Immune Escape of Influenza Virus by Suppressing Interferon-beta Production.
    J Virol. 2017 Apr 12. pii: JVI.02260-16. doi: 10.1128/JVI.02260.
    PubMed     Text format     Abstract available


  19. DU Y, Chen M, Yang J, Jia Y, et al
    Molecular Evolution and Emergence of H5N6 Avian Influenza Virus in Central China.
    J Virol. 2017 Apr 12. pii: JVI.00143-17. doi: 10.1128/JVI.00143.
    PubMed     Text format     Abstract available


  20. SANTOS JJ, Finch C, Sutton T, Obadan A, et al
    Development of an alternative modified live Influenza B virus vaccine.
    J Virol. 2017 Apr 5. pii: JVI.00056-17. doi: 10.1128/JVI.00056.
    PubMed     Text format     Abstract available


  21. ZHAO D, Liang L, Wang S, Nakao T, et al
    Glycosylation of the Hemagglutinin Protein of H5N1 Influenza Virus Increases Its Virulence in Mice by Exacerbating the Host Immune Response.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


  22. PALMENBERG AC
    Rhinovirus C, Asthma, and Cell Surface Expression of Virus Receptor CDHR3.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


  23. LEWIS-ROGERS N, Seger J, Adler FR
    Human Rhinovirus Diversity and Evolution: How Strange the Change from Major to Minor.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


    March 2017
  24. BOBONE S, Hilsch M, Storm J, Dunsing V, et al
    Phosphatidylserine Lateral Organization Influences the Interaction of Influenza Matrix Protein 1 with Lipid Membranes.
    J Virol. 2017 Mar 29. pii: JVI.00267-17. doi: 10.1128/JVI.00267.
    PubMed     Text format     Abstract available


  25. GERLACH T, Hensen L, Matrosovich T, Bergmann J, et al
    pH-optimum of hemagglutinin-mediated membrane fusion determines sensitivity of influenza A viruses to the interferon-induced antiviral state and IFITMs.
    J Virol. 2017 Mar 29. pii: JVI.00246-17. doi: 10.1128/JVI.00246.
    PubMed     Text format     Abstract available


  26. BENTON DJ, Wharton SA, Martin SR, McCauley JW, et al
    Role of Neuraminidase in Influenza A(H7N9) Receptor Binding.
    J Virol. 2017 Mar 29. pii: JVI.02293-16. doi: 10.1128/JVI.02293.
    PubMed     Text format     Abstract available


  27. ERMLER M, Kirkpatrick E, Sun W, Hai R, et al
    Chimeric hemagglutinin constructs induce broad protection against influenza B virus challenge in the mouse model.
    J Virol. 2017 Mar 29. pii: JVI.00286-17. doi: 10.1128/JVI.00286.
    PubMed     Text format     Abstract available


  28. WANG S, Ren H, Jiang W, Chen H, et al
    Divergent requirement of Fc-FcgammaR interactions for in vivo protection against influenza viruses by two pan-H5 hemagglutinin antibodies.
    J Virol. 2017 Mar 22. pii: JVI.02065-16. doi: 10.1128/JVI.02065.
    PubMed     Text format     Abstract available


  29. WHITE MC, Steel J, Lowen AC
    Heterologous packaging signals on HA, but not NA or NS, limit influenza A virus reassortment.
    J Virol. 2017 Mar 22. pii: JVI.00195-17. doi: 10.1128/JVI.00195.
    PubMed     Text format     Abstract available


  30. COBBIN JC, Alfelali M, Barasheed O, Taylor J, et al
    Multiple sources of genetic diversity of influenza A viruses during the Hajj.
    J Virol. 2017 Mar 22. pii: JVI.00096-17. doi: 10.1128/JVI.00096.
    PubMed     Text format     Abstract available


  31. KWON HI, Kim YI, Park SJ, Song MS, et al
    Evaluation of the immune responses to and cross-protective efficacy of Eurasian H7 avian influenza viruses.
    J Virol. 2017 Mar 22. pii: JVI.02259-16. doi: 10.1128/JVI.02259.
    PubMed     Text format     Abstract available


  32. TIAN B, Yang J, Zhao Y, Ivanciuc T, et al
    BRD4 Couples NF-kappaB/RelA with Airway Inflammation and the IRF-RIG-I Amplification Loop in Respiratory Syncytial Virus Infection.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


  33. LINGEMANN M, Liu X, Surman S, Liang B, et al
    Attenuated Human Parainfluenza Virus type 1 expressing Ebola Virus Glycoprotein GP Administered Intranasally is Immunogenic in African Green Monkeys.
    J Virol. 2017 Mar 1. pii: JVI.02469-16. doi: 10.1128/JVI.02469.
    PubMed     Text format     Abstract available


  34. SCHIERHORN KL, Jolmes F, Bespalowa J, Saenger S, et al
    Influenza A virus virulence depends on two amino acids in the N-terminal domain of its NS1 protein facilitating inhibition of PKR.
    J Virol. 2017 Mar 1. pii: JVI.00198-17. doi: 10.1128/JVI.00198.
    PubMed     Text format     Abstract available


  35. ZHANG Z, Dong Z, Wei Q, Carr MJ, et al
    A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy.
    J Virol. 2017 Mar 1. pii: JVI.02450-16. doi: 10.1128/JVI.02450.
    PubMed     Text format     Abstract available


    February 2017
  36. LESER GP, Lamb RA
    The lateral organization of influenza virus proteins in the budozone region of the plasma membrane.
    J Virol. 2017 Feb 15. pii: JVI.02104-16. doi: 10.1128/JVI.02104.
    PubMed     Text format     Abstract available


  37. XU Y, Ramey AM, Bowman AS, DeLiberto TJ, et al
    Low Pathogenic Influenza A Viruses in North American Diving Ducks Contribute to the Emergence of a Novel Highly Pathogenic Influenza A(H7N8) Virus.
    J Virol. 2017 Feb 15. pii: JVI.02208-16. doi: 10.1128/JVI.02208.
    PubMed     Text format     Abstract available


  38. DAI M, McBride R, Dortmans JC, Peng W, et al
    Mutation of the 2nd Sialic Acid-Binding Site Resulting in Reduced Neuraminidase Activity Preceded Emergence of H7N9 Influenza A Virus.
    J Virol. 2017 Feb 15. pii: JVI.00049-17. doi: 10.1128/JVI.00049.
    PubMed     Text format     Abstract available


  39. JIANG W, Wang S, Chen H, Ren H, et al
    A bivalent heterologous DNA-virus-like particles prime-boost vaccine elicits broad protection against both groups 1 and 2 influenza A viruses.
    J Virol. 2017 Feb 8. pii: JVI.02052-16. doi: 10.1128/JVI.02052.
    PubMed     Text format     Abstract available


  40. MATSUMOTO Y, Ohta K, Kolakofsky D, Nishio M, et al
    A point mutation in the RNA-binding domain of human parainfluenza virus type 2 nucleoprotein elicits an abnormally enhanced polymerase activity.
    J Virol. 2017 Feb 8. pii: JVI.02203-16. doi: 10.1128/JVI.02203.
    PubMed     Text format     Abstract available


  41. HALL OJ, Nachbagauer R, Vermillion MS, Fink AL, et al
    Progesterone-based contraceptives reduce adaptive immune responses and protection against sequential influenza A virus infections.
    J Virol. 2017 Feb 8. pii: JVI.02160-16. doi: 10.1128/JVI.02160.
    PubMed     Text format     Abstract available


  42. PU J, Sun H, Qu Y, Wang C, et al
    M gene reassortment in H9N2 influenza virus promotes early infection and replication: contribution to rising virus prevalence in chickens in China.
    J Virol. 2017 Feb 1. pii: JVI.02055-16. doi: 10.1128/JVI.02055.
    PubMed     Text format     Abstract available


  43. YANG W, Punyadarsaniya D, Lambertz RL, Lee DC, et al
    Mutations during the adaptation of H9N2 avian influenza virus to the respiratory epithelium of pigs enhance the sialic acid binding activity and the virulence in mice.
    J Virol. 2017 Feb 1. pii: JVI.02125-16. doi: 10.1128/JVI.02125.
    PubMed     Text format     Abstract available


  44. SCHNEIDER-OHRUM K, Cayatte C, Snell Bennett A, Manohar Rajani G, et al
    Immunization with low doses of recombinant post-fusion or pre-fusion RSV F primes for vaccine-enhanced disease in the cotton rat model independent of the presence of a Th1-biasing (GLA-SE) or Th2-biasing (Alum) adjuvant.
    J Virol. 2017 Feb 1. pii: JVI.02180-16. doi: 10.1128/JVI.02180.
    PubMed     Text format     Abstract available


    January 2017
  45. NILSSON BE, Te Velthuis AJ, Fodor E
    The role of the PB2 627-domain in influenza A virus polymerase function.
    J Virol. 2017 Jan 25. pii: JVI.02467-16. doi: 10.1128/JVI.02467.
    PubMed     Text format     Abstract available


  46. TANG X, Yang Y, Xia X, Zhang C, et al
    Recombinant adenoviruses displaying matrix 2 ectodomain epitopes (M2e) on their fiber proteins as universal influenza vaccines.
    J Virol. 2017 Jan 18. pii: JVI.02462-16. doi: 10.1128/JVI.02462.
    PubMed     Text format     Abstract available


  47. VAN DEN HOECKE S, Ehrhardt K, Kolpe A, El Bakkouri K, et al
    Hierarchical and redundant roles of activating FcgammaRs in protection against influenza disease by M2e-specific IgG1 and IgG2a antibodies.
    J Virol. 2017 Jan 11. pii: JVI.02500-16. doi: 10.1128/JVI.02500.
    PubMed     Text format     Abstract available


  48. VAN DEN POL AN, Mao G, Chattopadhyay A, Rose JK, et al
    Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the Brain.
    J Virol. 2017 Jan 11. pii: JVI.02154-16. doi: 10.1128/JVI.02154.
    PubMed     Text format     Abstract available


  49. KIM SM, Kim YI, Park SJ, Kim EH, et al
    Vaccine efficacy of an inactivated, chimeric HA H9/H5N2 avian influenza virus and its suitability for the marker vaccine strategy.
    J Virol. 2017 Jan 11. pii: JVI.01693-16. doi: 10.1128/JVI.01693.
    PubMed     Text format     Abstract available


  50. NAITO T, Mori K, Ushirogawa H, Takizawa N, et al
    Generation of a genetically stable high-fidelity influenza vaccine strain.
    J Virol. 2017 Jan 4. pii: JVI.01073-16. doi: 10.1128/JVI.01073.
    PubMed     Text format     Abstract available


    December 2016
  51. LI C, Wang Z, Cao Y, Wang L, et al
    Screening for novel small molecule inhibitors targeting the assembling of influenza virus polymerase complex by a BiLC-based reporter system.
    J Virol. 2016 Dec 28. pii: JVI.02282-16. doi: 10.1128/JVI.02282.
    PubMed     Text format     Abstract available


  52. YANG L, Zhu W, Li X, Bo H, et al
    Genesis and dissemination of highly pathogenic H5N6 avian influenza viruses.
    J Virol. 2016 Dec 21. pii: JVI.02199-16. doi: 10.1128/JVI.02199.
    PubMed     Text format     Abstract available


  53. NOGALES A, Martinez-Sobrido L, Topham DJ, DeDiego ML, et al
    NS1 protein amino acid changes D189N and V194I affect interferon responses, thermosensitivity and virulence of circulating H3N2 human influenza A viruses.
    J Virol. 2016 Dec 21. pii: JVI.01930-16. doi: 10.1128/JVI.01930.
    PubMed     Text format     Abstract available


  54. NGUYEN DT, Jang Y, Nguyen TD, Jones J, et al
    Shifting clade distribution, reassortment, and emergence of new subtypes of highly pathogenic avian influenza A(H5) viruses collected in Vietnamese poultry from 2012 to 2015.
    J Virol. 2016 Dec 21. pii: JVI.01708-16. doi: 10.1128/JVI.01708.
    PubMed     Text format     Abstract available


  55. NOGALES A, Rodriguez L, Chauche C, Huang K, et al
    A temperature sensitive live-attenuated canine influenza virus H3N8 vaccine.
    J Virol. 2016 Dec 7. pii: JVI.02211.
    PubMed     Text format     Abstract available


  56. RAJAO DS, Walia R, Campbell B, Gauger PC, et al
    Reassortment between swine H3N2 and 2009 pandemic H1N1 in the United States resulted in influenza A viruses with diverse genetic constellations with variable virulence in pigs.
    J Virol. 2016 Dec 7. pii: JVI.01763.
    PubMed     Text format     Abstract available


    November 2016
  57. ZHANG S, Jiang Y, Cheng Q, Yi Z, et al
    Inclusion body fusion of human parainfluenza virus type 3 regulated by acetylated alpha-tubulin enhances viral replication.
    J Virol. 2016 Nov 23. pii: JVI.01802.
    PubMed     Text format     Abstract available


  58. MINAKUCHI M, Sugiyama K, Kato Y, Naito T, et al
    Pre-mRNA processing factor Prp18 is a stimulatory factor of influenza virus RNA synthesis and possesses the NP chaperone activity.
    J Virol. 2016 Nov 16. pii: JVI.01398.
    PubMed     Text format     Abstract available


  59. ZANIN M, Kocer ZA, Poulson RL, Gabbard JD, et al
    The Potential for Low Pathogenic Avian H7 Influenza A Viruses to Replicate and Cause Disease in a Mammalian Model.
    J Virol. 2016 Nov 16. pii: JVI.01934.
    PubMed     Text format     Abstract available


  60. MARVIN SA, Russier M, Huerta CT, Russell CJ, et al
    Influenza overcomes cellular blocks to productively replicate impacting macrophage function.
    J Virol. 2016 Nov 2. pii: JVI.01417.
    PubMed     Text format     Abstract available


  61. CROSBY CM, Matchett WE, Anguiano-Zarate SS, Parks CA, et al
    Replicating Single-cycle Adenovirus Vectors Generate Amplified Influenza Vaccine Responses.
    J Virol. 2016 Nov 2. pii: JVI.00720.
    PubMed     Text format     Abstract available


  62. TANG Q, Wang X, Gao G
    ZAPS inhibits influenza A viral protein expression and is antagonized by the virus encoded NS1.
    J Virol. 2016 Nov 2. pii: JVI.01909.
    PubMed     Text format     Abstract available


  63. IWATSUKI-HORIMOTO K, Nakajima N, Shibata M, Takahashi K, et al
    Microminipigs as an animal model for influenza A virus infection.
    J Virol. 2016 Nov 2. pii: JVI.01716.
    PubMed     Text format     Abstract available


  64. WANG X, Ilyushina NA, Lugovtsev VY, Bovin NV, et al
    Amino Acids in Hemagglutinin Antigenic Site B Determine Antigenic and Receptor Binding Differences between A(H3N2)v and Ancestral Seasonal H3N2 Influenza Viruses.
    J Virol. 2016 Nov 2. pii: JVI.01512.
    PubMed     Text format     Abstract available


    October 2016
  65. WANG J, Li J, Zhao L, Cao M, et al
    The dual roles of the HA segment-specific noncoding nucleotides in the extended duplex region of the influenza A virus RNA promoter.
    J Virol. 2016 Oct 26. pii: JVI.01931.
    PubMed     Text format     Abstract available


  66. TENG O, Chen ST, Hsu TL, Sia SF, et al
    CLEC5A-mediated enhancement of the inflammatory response in myeloid cells contributes to influenza pathogenicity in vivo.
    J Virol. 2016 Oct 19. pii: JVI.01813.
    PubMed     Text format     Abstract available


  67. ZHU P, Liang L, Shao X, Luo W, et al
    Host cellular protein TRAPPC6ADelta interacts with influenza A virus M2 protein and regulates viral propagation by modulating M2 trafficking.
    J Virol. 2016 Oct 19. pii: JVI.01757.
    PubMed     Text format     Abstract available


  68. TAKEMAE N, Harada M, Nguyen PT, Nguyen T, et al
    Vietnamese influenza A viruses of swine between 2010 and 2015: multiple introductions of A(H1N1)pdm09 viruses into the pig population and diversifying genetic constellations of enzootic IAV-S.
    J Virol. 2016 Oct 19. pii: JVI.01490.
    PubMed     Text format     Abstract available


  69. SOBEL LEONARD A, McClain MT, Smith GJ, Wentworth D, et al
    Deep Sequencing of Influenza A Virus from a Human Challenge Study Reveals a Selective Bottleneck and Only Limited Intrahost Genetic Diversification.
    J Virol. 2016 Oct 5. pii: JVI.01657.
    PubMed     Text format     Abstract available


  70. SUN X, Zeng H, Kumar A, Belser JA, et al
    Constitutively expressed IFITM3 protein in human pulmonary endothelial cells poses an early infection block to human influenza viruses.
    J Virol. 2016 Oct 5. pii: JVI.01254.
    PubMed     Text format     Abstract available


  71. RABBANI MA, Ribaudo M, Guo JT, Barik S, et al
    Identification of IFN-stimulated gene (ISG) proteins that inhibit human parainfluenza virus type 3.
    J Virol. 2016 Oct 5. pii: JVI.01551.
    PubMed     Text format     Abstract available


    September 2016
  72. NELSON MI, Stucker KM, Schobel SA, Trovao NS, et al
    Introduction, evolution, and dissemination of influenza A viruses in exhibition swine, USA, 2009-2013.
    J Virol. 2016 Sep 28. pii: JVI.01457.
    PubMed     Text format     Abstract available


  73. SUN X, Belser JA, Pulit-Penaloza JA, Zeng H, et al
    Pathogenesis and transmission assessments of two H7N8 influenza A viruses recently isolated from turkey farms in Indiana using mouse and ferret models.
    J Virol. 2016 Sep 28. pii: JVI.01646.
    PubMed     Text format     Abstract available


  74. KIRUI J, Mondal A, Mehle A
    Ubiquitination up-regulates influenza virus polymerase function.
    J Virol. 2016 Sep 28. pii: JVI.01829.
    PubMed     Text format     Abstract available


  75. WU Y, Gao F, Qi J, Bi Y, et al
    Resistance to mutant group-2 influenza neuraminidases of an oseltamivir-zanamivir hybrid inhibitor.
    J Virol. 2016 Sep 21. pii: JVI.01703.
    PubMed     Text format     Abstract available


  76. NURNBERGER C, Zimmermann V, Gerhardt M, Staeheli P, et al
    Influenza virus susceptibility of wild-derived CAST/EiJ mice results from two amino acid changes in the MX1 restriction factor.
    J Virol. 2016 Sep 21. pii: JVI.01213.
    PubMed     Text format     Abstract available


  77. MARJUKI H, Mishin VP, Chai N, Tan MW, et al
    Human monoclonal antibody 81.39a effectively neutralizes emerging influenza A viruses of group 1 and 2 hemagglutinins.
    J Virol. 2016 Sep 14. pii: JVI.01284.
    PubMed     Text format     Abstract available


  78. DINIS JM, Florek NW, Fatola OO, Moncla LH, et al
    Correction for Dinis et al., Deep Sequencing Reveals Potential Antigenic Variants at Low Frequencies in Influenza A Virus-Infected Humans.
    J Virol. 2016;90:8029.
    PubMed     Text format    


    August 2016
  79. ALTENBURG AF, van de Sandt CE, van Trierum SE, De Gruyter HL, et al
    Increased Protein Degradation Improves Influenza Virus Nucleoprotein-specific CD8+ T cell Activation in vitro but not in C57BL/6 mice.
    J Virol. 2016 Aug 31. pii: JVI.01633.
    PubMed     Text format     Abstract available


  80. FABRIZIO TP, Sun Y, Yoon SW, Jeevan T, et al
    Virologic differences do not fully explain the diversification of swine influenza viruses in the United States.
    J Virol. 2016 Aug 31. pii: JVI.01218.
    PubMed     Text format     Abstract available


  81. LIANG B, Ngwuta JO, Herbert R, Swerczek J, et al
    Packaging and prefusion stabilization separately and additively increase the quantity and quality of RSV-neutralizing antibodies induced by respiratory syncytial virus (RSV) fusion protein expressed by a parainfluenza vector.
    J Virol. 2016 Aug 31. pii: JVI.01196.
    PubMed     Text format     Abstract available


  82. PANTIN-JACKWOOD MJ, Costa-Hurtado M, Shepherd E, DeJesus E, et al
    Pathogenicity and transmission of H5 and H7 highly pathogenic avian influenza viruses in mallards.
    J Virol. 2016 Aug 24. pii: JVI.01165.
    PubMed     Text format     Abstract available


  83. RANADHEERA C, Hagan MW, Leung A, Collignon B, et al
    Reduction of neuraminidase activity exacerbates disease in 2009 pandemic influenza virus-infected mice.
    J Virol. 2016 Aug 24. pii: JVI.01188.
    PubMed     Text format     Abstract available


  84. LIU L, Zeng X, Chen P, Deng G, et al
    Characterization of Clade 7.2 H5 Avian Influenza Viruses That Continue to Circulate in Chickens in China.
    J Virol. 2016 Aug 24. pii: JVI.00855.
    PubMed     Text format     Abstract available


  85. TENG Q, Xu D, Shen W, Liu Q, et al
    A Single Mutation at Position 190 in Hemagglutinin Enhances Binding Affinity for Human Type Sialic Acid Receptor and Replication of H9N2 Avian Influenza Virus in Mice.
    J Virol. 2016 Aug 24. pii: JVI.01141.
    PubMed     Text format     Abstract available


  86. DEDIEGO ML, Nogales A, Lambert-Emo K, Martinez-Sobrido L, et al
    An NS1 protein mutation (I64T) affects interferon responses and virulence of circulating H3N2 human influenza A viruses.
    J Virol. 2016 Aug 17. pii: JVI.01039.
    PubMed     Text format     Abstract available


  87. HURT AC, Su YC, Aban M, Peck H, et al
    Evidence for the introduction, reassortment and persistence of diverse influenza A viruses in Antarctica.
    J Virol. 2016 Aug 17. pii: JVI.01404.
    PubMed     Text format     Abstract available


  88. DAI M, Guo H, Dortmans J, Dekkers J, et al
    Identification of residues that affect oligomerization and/or enzymatic activity of influenza virus H5N1 neuraminidase proteins.
    J Virol. 2016 Aug 10. pii: JVI.01346.
    PubMed     Text format     Abstract available


  89. OHTA K, Goto H, Matsumoto Y, Yumine N, et al
    Graf1 controls the growth of human parainfluenza virus type 2 through inactivation of RhoA signaling.
    J Virol. 2016 Aug 10. pii: JVI.01471.
    PubMed     Text format     Abstract available


  90. TALKER SC, Stadler M, Koinig HC, Mair KH, et al
    Influenza A virus infection in pigs attracts multifunctional and cross-reactive T cells to the lung.
    J Virol. 2016 Aug 10. pii: JVI.01211.
    PubMed     Text format     Abstract available


  91. KHURANA S, Chung KY, Coyle EM, Meijer A, et al
    Antigenic fingerprinting of antibody response following highly pathogenic H7N7 avian influenza virus exposure in humans: Evidence for anti-PA-X antibodies.
    J Virol. 2016 Aug 10. pii: JVI.01408.
    PubMed     Text format     Abstract available


  92. TURNBULL ML, Wise HM, Nicol MQ, Smith N, et al
    The Role of the B-Allele of the Influenza A Virus Segment 8 in Setting Mammalian Host Range and Pathogenicity.
    J Virol. 2016 Aug 3. pii: JVI.01205.
    PubMed     Text format     Abstract available


    July 2016
  93. LONG JC, Fodor E
    The PB2 subunit of the influenza A virus RNA polymerase is imported into the mitochondrial matrix.
    J Virol. 2016 Jul 20. pii: JVI.01384.
    PubMed     Text format     Abstract available


  94. WEBER-GERLACH M, Weber F
    To conquer the host, Influenza virus is packing it in: interferon-antagonistic strategies beyond NS1.
    J Virol. 2016 Jul 20. pii: JVI.00041.
    PubMed     Text format     Abstract available


  95. LIU WC, Jan JT, Huang YJ, Chen TH, et al
    Unmasking stem-specific neutralizing epitopes by abolishing N-linked glycosylation sites of influenza hemagglutinin proteins for vaccine design.
    J Virol. 2016 Jul 20. pii: JVI.00880.
    PubMed     Text format     Abstract available


  96. ZHOU B, Meliopoulos VA, Wang W, Lin X, et al
    Reversion of Cold-adapted Live Attenuated Influenza Vaccine into a Pathogenic Virus.
    J Virol. 2016 Jul 20. pii: JVI.00163.
    PubMed     Text format     Abstract available


  97. MATSUZAKI Y, Sugawara K, Furuse Y, Shimotai Y, et al
    Genetic lineage and reassortment of influenza C viruses circulating between 1947 and 2014.
    J Virol. 2016 Jul 6. pii: JVI.00969.
    PubMed     Text format     Abstract available


  98. ABENTE EJ, Santos J, Lewis NS, Gauger PC, et al
    The molecular determinants of antibody recognition and antigenic drift in the H3 hemagglutinin of swine influenza A virus.
    J Virol. 2016 Jul 6. pii: JVI.01002.
    PubMed     Text format     Abstract available


  99. XU G, Zhang X, Gao W, Wang C, et al
    Prevailing PA mutation K356R in avian influenza H9N2 virus increases mammalian replication and pathogenicity.
    J Virol. 2016 Jul 6. pii: JVI.00883.
    PubMed     Text format     Abstract available


    June 2016
  100. DAM S, Kracht M, Pleschka S, Schmitz ML, et al
    The influenza A virus genotype determines the anti-viral function of NF-kappaB.
    J Virol. 2016 Jun 29. pii: JVI.00946.
    PubMed     Text format     Abstract available


  101. DIPIAZZA A, Richards K, Batarse F, Lockard L, et al
    Flow Cytometric and Cytokine ELISpot Approaches to Characterize the Cell-mediated Immune Response in Ferrets Following Influenza Virus Infection.
    J Virol. 2016 Jun 29. pii: JVI.01001.
    PubMed     Text format     Abstract available


  102. ROSTAD CA, Stobart CC, Gilbert BE, Pickles RJ, et al
    A recombinant respiratory syncytial virus vaccine candidate attenuated by a low-fusion F protein is immunogenic and protective against challenge in cotton rats.
    J Virol. 2016 Jun 8. pii: JVI.00012.
    PubMed     Text format     Abstract available


  103. WEISSHAAR M, Cox R, Morehouse Z, Kyasa S, et al
    Identification and Characterization of Influenza Virus Entry Inhibitors Through Dual-Myxovirus High-Throughput Screening.
    J Virol. 2016 Jun 1. pii: JVI.00898.
    PubMed     Text format     Abstract available


  104. PALOMO C, Mas V, Thom M, Vazquez M, et al
    Influence of Respiratory Syncytial Virus F Glycoprotein Conformation on Induction of Protective Immune Responses.
    J Virol. 2016;90:5485-98.
    PubMed     Text format     Abstract available


    May 2016
  105. HAYASHI T, Chaimayo C, McGuinness J, Takimoto T, et al
    Critical role of the PA-X C-terminal domain of influenza A virus on its subcellular localization and shutoff activity.
    J Virol. 2016 May 25. pii: JVI.00954.
    PubMed     Text format     Abstract available


  106. KO EJ, Lee YT, Kim KH, Jung YJ, et al
    MF59 adjuvant effects on inducing isotype-switched IgG antibodies and protection after immunization with T-dependent influenza virus vaccine in the absence of CD4+ T cells.
    J Virol. 2016 May 25. pii: JVI.00339.
    PubMed     Text format     Abstract available


  107. QUINONES-PARRA SM, Clemens EB, Wang Z, Croom HA, et al
    A role of influenza exposure history in determining pandemic susceptibility and CD8+ T cell responses.
    J Virol. 2016 May 25. pii: JVI.00349.
    PubMed     Text format     Abstract available


  108. GUI L, Ebner JL, Mileant A, Williams JA, et al
    Visualization and sequencing of membrane remodeling leading to influenza virus fusion.
    J Virol. 2016 May 25. pii: JVI.00240.
    PubMed     Text format     Abstract available


  109. KAMLANGDEE A, Kingstad-Bakke B, Osorio JE
    Mosaic H5 hemagglutinin provides broad humoral and cellular immune responses against influenza viruses.
    J Virol. 2016 May 18. pii: JVI.00730.
    PubMed     Text format     Abstract available


  110. LEE YT, Ko EJ, Lee Y, Lee YN, et al
    CD47 plays a role as a negative regulator in inducing protective immune responses to vaccination against influenza virus.
    J Virol. 2016 May 18. pii: JVI.00605.
    PubMed     Text format     Abstract available


  111. SHARMA A, Wu W, Sung B, Huang J, et al
    Respiratory Syncytial Virus (RSV) Pulmonary Infection in Humanized Mice Induces Human Anti-RSV Immune Responses and Pathology.
    J Virol. 2016;90:5068-74.
    PubMed     Text format     Abstract available


  112. OTIENO JR, Agoti CN, Gitahi CW, Bett A, et al
    Molecular Evolutionary Dynamics of Respiratory Syncytial Virus Group A in Recurrent Epidemics in Coastal Kenya.
    J Virol. 2016;90:4990-5002.
    PubMed     Text format     Abstract available


  113. ALJABR W, Touzelet O, Pollakis G, Wu W, et al
    Investigating the Influence of Ribavirin on Human Respiratory Syncytial Virus RNA Synthesis by Using a High-Resolution Transcriptome Sequencing Approach.
    J Virol. 2016;90:4876-88.
    PubMed     Text format     Abstract available


  114. FAN S, Wu Y, Wang S, Wang Z, et al
    Structural and biochemical analyses of swine MHC class I complexes and prediction of the epitope map in important influenza A strains.
    J Virol. 2016 May 11. pii: JVI.00119.
    PubMed     Text format     Abstract available


  115. HOA LN, Mai LQ, Bryant JE, Thai PQ, et al
    Association between HA stem-reactive antibodies and influenza A/H1N1 infection during the 2009 pandemic.
    J Virol. 2016 May 11. pii: JVI.00093.
    PubMed     Text format     Abstract available


  116. FUSARO A, Tassoni L, Milani A, Hughes J, et al
    Unexpected Inter-farm Transmission Dynamics During a Highly Pathogenic Avian Influenza Epidemic.
    J Virol. 2016 May 4. pii: JVI.00538.
    PubMed     Text format     Abstract available


    April 2016
  117. NOGALES A, DeDiego ML, Topham DJ, Martinez-Sobrido L, et al
    Rearrangement of influenza virus spliced segments for the development of live attenuated vaccines.
    J Virol. 2016 Apr 27. pii: JVI.00410.
    PubMed     Text format     Abstract available


  118. JIANG J, Li J, Fan W, Zheng W, et al
    Robust Lys63-linked Ubiquitination of RIG-I Promotes Cytokine Eruption in Early Influenza B Virus Infection.
    J Virol. 2016 Apr 27. pii: JVI.00549.
    PubMed     Text format     Abstract available


  119. SUN H, Pu J, Wei Y, Sun Y, et al
    Highly pathogenic avian influenza H5N6 viruses exhibit enhanced affinity for human type sialic acid receptor and in-contact transmission in model ferrets.
    J Virol. 2016 Apr 27. pii: JVI.00127.
    PubMed     Text format     Abstract available


  120. LIU WC, Lin YL, Spearman M, Cheng PY, et al
    Influenza Hemagglutinin Glycoproteins with Different N-glycan Patterns Activate Dendritic Cells in Vitro.
    J Virol. 2016 Apr 20. pii: JVI.00452.
    PubMed     Text format     Abstract available


  121. MARTINEZ-ALONSO M, Hengrung N, Fodor E
    RNA-free and ribonucleoprotein-associated influenza virus polymerases directly bind the serine-5 phosphorylated carboxyl-terminal domain of host RNA polymerase II.
    J Virol. 2016 Apr 20. pii: JVI.00494.
    PubMed     Text format     Abstract available


  122. MANZ B, de Graaf M, Mogling R, Richard M, et al
    Multiple Natural Substitutions in Avian Influenza A Virus PB2 Facilitate Efficient Replication in Human Cells.
    J Virol. 2016 Apr 13. pii: JVI.00130.
    PubMed     Text format     Abstract available


  123. YANG H, Carney PJ, Mishin VP, Guo Z, et al
    The molecular characterizations of surface proteins hemagglutinin and neuraminidase from recent H5Nx avian influenza viruses.
    J Virol. 2016 Apr 6. pii: JVI.00180.
    PubMed     Text format     Abstract available


  124. KRISTENSEN AB, Lay WN, Ana-Sosa-Batiz F, Vanderven HA, et al
    Antibody responses with Fc-mediated functions after trivalent influenza vaccination of HIV-infected subjects.
    J Virol. 2016 Apr 6. pii: JVI.00285.
    PubMed     Text format     Abstract available


    March 2016
  125. FERGUSON L, Olivier AK, Genova S, Epperson WB, et al
    Pathogenesis of Influenza D virus in Cattle.
    J Virol. 2016 Mar 30. pii: JVI.03122.
    PubMed     Text format     Abstract available


  126. WANG D, Yang L, Zhu W, Zhang Y, et al
    Two outbreak sources of influenza A (H7N9) viruses have been established in China.
    J Virol. 2016 Mar 30. pii: JVI.03173.
    PubMed     Text format     Abstract available


  127. WILLIAMS GD, Pinto AK, Doll B, Boon AC, et al
    A North American H7N3 influenza virus supports reassortment with 2009 pandemic H1N1 and induces disease in mice without prior adaptation.
    J Virol. 2016 Mar 2. pii: JVI.02761.
    PubMed     Text format     Abstract available


  128. ZANG N, Zhuang J, Deng Y, Yang Z, et al
    Pulmonary C Fibers Modulate MMP-12 Production via PAR2 and Are Involved in the Long-Term Airway Inflammation and Airway Hyperresponsiveness Induced by Respiratory Syncytial Virus Infection.
    J Virol. 2015;90:2536-43.
    PubMed     Text format     Abstract available


  129. FORERO A, Tisoncik-Go J, Watanabe T, Zhong G, et al
    The 1918 Influenza Virus PB2 Protein Enhances Virulence through the Disruption of Inflammatory and Wnt-Mediated Signaling in Mice.
    J Virol. 2015;90:2240-53.
    PubMed     Text format     Abstract available


  130. EBERLE KC, McGill JL, Reinhardt TA, Sacco RE, et al
    Parainfluenza Virus 3 Blocks Antiviral Mediators Downstream of the Interferon Lambda Receptor by Modulating Stat1 Phosphorylation.
    J Virol. 2015;90:2948-58.
    PubMed     Text format     Abstract available


    February 2016
  131. NAGESH PT, Husain M
    Influenza A virus dysregulates host histone deacetylase 1 that inhibits viral infection in lung epithelial cells.
    J Virol. 2016 Feb 24. pii: JVI.00126.
    PubMed     Text format     Abstract available


  132. RUSSELL RF, McDonald JU, Lambert L, Tregoning JS, et al
    Use of the microparticle Nano-SiO2 as an adjuvant to boost vaccine immune responses in neonatal mice against influenza.
    J Virol. 2016 Feb 24. pii: JVI.03159.
    PubMed     Text format     Abstract available


  133. CARTER DM, Darby CA, LeFoley BC, Crevar CJ, et al
    Design and Characterization of a COBRA HA vaccine for H1N1 influenza viruses.
    J Virol. 2016 Feb 24. pii: JVI.03152.
    PubMed     Text format     Abstract available


  134. RUANGRUNG K, Suptawiwat O, Maneechotesuwan K, Boonarkart C, et al
    Neuraminidase Activity and The Resistance of 2009 Pandemic H1N1 Influenza Virus to Antiviral Activity in Bronchoalveolar Fluid.
    J Virol. 2016 Feb 24. pii: JVI.00013.
    PubMed     Text format     Abstract available


  135. BELSER JA, Creager HM, Sun X, Gustin KM, et al
    Mammalian pathogenesis and transmission of H7N9 influenza viruses from three waves, 2013-2015.
    J Virol. 2016 Feb 24. pii: JVI.00134.
    PubMed     Text format     Abstract available


  136. KUO RL, Li LH, Lin SJ, Li ZH, et al
    The role of N-terminus-truncated NS1 proteins of influenza A virus in inhibiting IRF3 activation.
    J Virol. 2016 Feb 24. pii: JVI.02843.
    PubMed     Text format     Abstract available


  137. KUHN N, Bergmann S, Kasnitz N, Lambertz RL, et al
    The proteolytic activation of A (H3N2) Influenza virus hemagglutinin is facilitated by different type II transmembrane serine proteases.
    J Virol. 2016 Feb 17. pii: JVI.02693.
    PubMed     Text format     Abstract available


  138. LIU B, Li NL, Shen Y, Bao X, et al
    The C-terminal Tail of TRIM56 Dictates Antiviral Restriction of Influenza A and B Viruses by Impeding Viral RNA Synthesis.
    J Virol. 2016 Feb 17. pii: JVI.03172.
    PubMed     Text format     Abstract available


  139. FUJIMOTO Y, Ito H, Ono E, Kawaoka Y, et al
    The low-pH resistance of neuraminidase is essential for the replication of influenza A virus in duck intestine following infection via the oral route.
    J Virol. 2016 Feb 10. pii: JVI.03107.
    PubMed     Text format     Abstract available


  140. MORIYAMA M, Chen IY, Kawaguchi A, Koshiba T, et al
    The RNA- and TRIM25-binding domains of influenza virus NS1 protein are essential for suppression of NLRP3 inflammasome-mediated IL-1beta secretion.
    J Virol. 2016 Feb 10. pii: JVI.00120.
    PubMed     Text format     Abstract available


  141. ZHANG J, Huang F, Tan L, Bai C, et al
    MOV10 is a Restriction Factor of Influenza A Virus by Inhibiting the Nuclear Import of the Viral Nucleoprotein.
    J Virol. 2016 Feb 3. pii: JVI.03137.
    PubMed     Text format     Abstract available


  142. EDENBOROUGH KM, Lowther S, Laurie K, Yamada M, et al
    Predicting Disease Severity and Viral Spread of H5N1 Influenza Virus in Ferrets in the Context of Natural Exposure Routes.
    J Virol. 2015;90:1888-97.
    PubMed     Text format     Abstract available


    January 2016
  143. BODEWES R, Zohari S, Krog JS, Hall MD, et al
    Spatiotemporal analysis of the genetic diversity of seal influenza A(H10N7) virus, Northwestern Europe.
    J Virol. 2016 Jan 27. pii: JVI.03046.
    PubMed     Text format     Abstract available


  144. MARCOS-VILLAR L, Pazo A, Nieto A
    Influenza virus and the chromatin: Role of CHD1 chromatin remodeler on virus life cycle.
    J Virol. 2016 Jan 20. pii: JVI.00053.
    PubMed     Text format     Abstract available


  145. MEYER L, Sausset A, Sedano L, Da Costa B, et al
    Codon deletions in the influenza A virus PA gene generate temperature-sensitive viruses.
    J Virol. 2016 Jan 20. pii: JVI.03101.
    PubMed     Text format     Abstract available


  146. THULASI RAMAN SN, Liu G, Pyo HM, Cui YC, et al
    DDX3 interacts with influenza A NS1 and NP proteins and exerts antiviral function through regulation of stress granule formation.
    J Virol. 2016 Jan 20. pii: JVI.03010.
    PubMed     Text format     Abstract available


  147. SCHRAUWEN EJ, Richard M, Burke DF, Rimmelzwaan GF, et al
    Amino acid substitutions that affect receptor binding and stability of the hemagglutinin of influenza A/H7N9 virus.
    J Virol. 2016 Jan 20. pii: JVI.03052.
    PubMed     Text format     Abstract available


  148. MOORE IN, Lamirande EW, Paskel M, Donahue D, et al
    Correction for Moore et al., Severity of Clinical Disease and Pathology in Ferrets Experimentally Infected with Influenza Viruses Is Influenced by Inoculum Volume.
    J Virol. 2015;90:1153.
    PubMed     Text format    


  149. CHEN CJ, Ermler ME, Tan GS, Krammer F, et al
    Influenza A viruses expressing intra- or inter-group chimeric hemagglutinins.
    J Virol. 2016 Jan 13. pii: JVI.03060.
    PubMed     Text format     Abstract available


  150. WANG J, Wu M, Hong W, Fan X, et al
    Infectivity and Transmissibility of Avian H9N2 Influenza Viruses in Pigs.
    J Virol. 2016 Jan 13. pii: JVI.02605.
    PubMed     Text format     Abstract available


  151. GONZALEZ-SANZ R, Mata M, Bermejo-Martin J, Alvarez A, et al
    ISG15 Is Upregulated in Respiratory Syncytial Virus Infection and Reduces Virus Growth through Protein ISGylation.
    J Virol. 2016;90:3428-38.
    PubMed     Text format     Abstract available


  152. MARTIN V, Pascual E, Avia M, Rangel G, et al
    A recombinant adenovirus expressing ovine interferon-tau prevents influenza virus induced lethality in mice.
    J Virol. 2016 Jan 6. pii: JVI.03258.
    PubMed     Text format     Abstract available


  153. DINIS JM, Florek NW, Fatola OO, Moncla LH, et al
    Deep sequencing reveals potential antigenic variants at low frequency in influenza A-infected humans.
    J Virol. 2016 Jan 6. pii: JVI.03248.
    PubMed     Text format     Abstract available


  154. SONG MS, Baek YH, Pascua PN, Kwon HI, et al
    Growth and Pathogenic Potential of Naturally Selected Reassortants after Coinfection with Pandemic H1N1 and Highly Pathogenic Avian Influenza H5N1 Viruses.
    J Virol. 2015;90:616-23.
    PubMed     Text format     Abstract available


  155. MENG J, Hotard AL, Currier MG, Lee S, et al
    Respiratory Syncytial Virus Attachment Glycoprotein Contribution to Infection Depends on the Specific Fusion Protein.
    J Virol. 2015;90:245-53.
    PubMed     Text format     Abstract available


  156. YOU D, Saravia J, Siefker D, Shrestha B, et al
    Crawling with Virus: Translational Insights from a Neonatal Mouse Model on the Pathogenesis of Respiratory Syncytial Virus in Infants.
    J Virol. 2015;90:2-4.
    PubMed     Text format     Abstract available


    December 2015
  157. HEMANN EA, Sjaastad LE, Langlois RA, Legge KL, et al
    Plasmacytoid dendritic cells require direct infection to sustain the pulmonary influenza A virus-specific CD8 T cell response.
    J Virol. 2015 Dec 30. pii: JVI.02546.
    PubMed     Text format     Abstract available


  158. HANSON A, Imai M, Hatta M, McBride R, et al
    Identification of Stabilizing Mutations in an H5 HA Influenza Virus Protein.
    J Virol. 2015 Dec 30. pii: JVI.02790.
    PubMed     Text format     Abstract available


  159. CAROLAN LA, Rockman S, Borg K, Guarnaccia T, et al
    Characterisation of the localised immune response in the respiratory tract of ferrets following infection with influenza A and B viruses.
    J Virol. 2015 Dec 30. pii: JVI.02797.
    PubMed     Text format     Abstract available


  160. NACHBAGAUER R, Miller MS, Hai R, Ryder AB, et al
    Hemagglutinin stalk immunity reduces influenza virus replication and transmission in ferrets.
    J Virol. 2015 Dec 30. pii: JVI.02481.
    PubMed     Text format     Abstract available


  161. WANG L, Wu A, Wang YE, Quanquin N, et al
    Functional Genomics Reveals Linkers Critical for Influenza Polymerase.
    J Virol. 2015 Dec 30. pii: JVI.02400.
    PubMed     Text format     Abstract available


  162. FEARS R, Ter Meulen V
    European academies advise on Gain of Function studies in influenza virus research.
    J Virol. 2015 Dec 23. pii: JVI.03045.
    PubMed     Text format     Abstract available


  163. RYDER AB, Nachbagauer R, Buonocore L, Palese P, et al
    Vaccination with VSV-vectored chimeric hemagglutinins protects mice against divergent influenza virus challenge strains.
    J Virol. 2015 Dec 16. pii: JVI.02598.
    PubMed     Text format     Abstract available


  164. LAI KK, Cheung NN, Yang F, Dai J, et al
    Identification of Novel Fusion Inhibitors of Influenza A Virus by Chemical Genetics.
    J Virol. 2015 Dec 16. pii: JVI.02326.
    PubMed     Text format     Abstract available


  165. XIA C, Vijayan M, Pritzl CJ, Fuchs SY, et al
    Hemagglutinin of influenza A virus antagonizes type I IFN responses by inducing degradation of type I IFN receptor 1.
    J Virol. 2015 Dec 16. pii: JVI.02749.
    PubMed     Text format     Abstract available


  166. COX A, Dewhurst S
    A single mutation at PB1 residue 319 dramatically increases the safety of PR8 LAIV in a murine model without compromising vaccine efficacy.
    J Virol. 2015 Dec 16. pii: JVI.02723.
    PubMed     Text format     Abstract available


  167. ZHANG G, Zhong Y, Qin Y, Chen M, et al
    Nucleoprotein of Human Parainfluenza Virus Type 3 interaction with Matrix protein Mediates Internal Viral Protein Assembly.
    J Virol. 2015 Dec 9. pii: JVI.02324.
    PubMed     Text format     Abstract available


  168. KANG MC, Choi DH, Choi YW, Park SJ, et al
    Intranasal introduction of Fc-fused interleukin-7 provides long-lasting prophylaxis from lethal influenza infection.
    J Virol. 2015 Dec 9. pii: JVI.02768.
    PubMed     Text format     Abstract available


  169. FENG X, Wang Z, Shi J, Deng G, et al
    Glycine at position 622 in PB1 contributes to the virulence of H5N1 avian influenza virus in mice.
    J Virol. 2015 Dec 9. pii: JVI.02387.
    PubMed     Text format     Abstract available


  170. NAKAMURA S, Horie M, Daidoji T, Honda T, et al
    Influenza A virus-induced expression of a GalNAc transferase, GALNT3, via miRNAs is required for enhanced viral replication.
    J Virol. 2015 Dec 4. pii: JVI.02246.
    PubMed     Text format     Abstract available


  171. SUGIYAMA M, Gamage A, Zyla R, Armstrong SM, et al
    Influenza infection induces platelet-endothelial adhesion which contributes to lung injury.
    J Virol. 2015 Dec 4. pii: JVI.02599.
    PubMed     Text format     Abstract available


  172. VILLENAVE R, Broadbent L, Douglas I, Lyons JD, et al
    Induction and Antagonism of Antiviral Responses in Respiratory Syncytial Virus-Infected Pediatric Airway Epithelium.
    J Virol. 2015;89:12309-18.
    PubMed     Text format     Abstract available


    November 2015
  173. BAUMANN J, Mounogou Kouassi N, Foni E, Klenk HD, et al
    H1N1 Swine Influenza Viruses Differ from Avian Precursors by a higher pH Optimum of Membrane Fusion.
    J Virol. 2015 Nov 25. pii: JVI.02332.
    PubMed     Text format     Abstract available


  174. LIANG L, Deng G, Shi J, Wang S, et al
    Genetics, receptor binding, replication and transmission in mammals of H4 avian influenza viruses isolated from live poultry markets in China.
    J Virol. 2015 Nov 18. pii: JVI.02692.
    PubMed     Text format     Abstract available


  175. KIRCHENBAUM GA, Carter DM, Ross TM
    Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Boosts Hemagglutinin Stalk-Specific Antibodies.
    J Virol. 2015 Nov 11. pii: JVI.02372.
    PubMed     Text format     Abstract available


  176. VAN DE SANDT CE, Kreijtz JH, Geelhoed-Mieras MM, Nieuwkoop NJ, et al
    Differential recognition of influenza A viruses by M158-66 epitope-specific CD8+ T cells is determined by extra-epitopic amino acid residues.
    J Virol. 2015 Nov 4. pii: JVI.02439.
    PubMed     Text format     Abstract available


  177. KOOPMAN G, Mooij P, Dekking L, Mortier D, et al
    Correlation between virus replication and antibody responses in macaques following infection with pandemic influenza A virus.
    J Virol. 2015 Nov 4. pii: JVI.02757.
    PubMed     Text format     Abstract available


  178. OUIZOUGUN-OUBARI M, Pereira N, Tarus B, Galloux M, et al
    A Druggable Pocket at the Nucleocapsid/Phosphoprotein Interaction Site of Human Respiratory Syncytial Virus.
    J Virol. 2015;89:11129-43.
    PubMed     Text format     Abstract available


  179. AGOTI CN, Otieno JR, Ngama M, Mwihuri AG, et al
    Successive Respiratory Syncytial Virus Epidemics in Local Populations Arise from Multiple Variant Introductions, Providing Insights into Virus Persistence.
    J Virol. 2015;89:11630-42.
    PubMed     Text format     Abstract available


    October 2015
  180. WOHLBOLD TJ, Chromikova V, Tan GS, Meade P, et al
    Hemagglutinin stalk- and neuraminidase-specific monoclonal antibodies protect against lethal H10N8 influenza virus infection in mice.
    J Virol. 2015 Oct 28. pii: JVI.02275.
    PubMed     Text format     Abstract available


  181. ABDELWHAB EM, Veits J, Tauscher K, Ziller M, et al
    A Unique Multibasic Proteolytic Cleavage Site and Three Mutations in the HA2 Domain Confer High Virulence of H7N1 Avian Influenza Virus in Chickens.
    J Virol. 2015 Oct 21. pii: JVI.02082.
    PubMed     Text format     Abstract available


  182. YAMAYOSHI S, Watanabe M, Goto H, Kawaoka Y, et al
    Identification of A Novel Viral Protein Expressed from the PB2 Segment of Influenza A Virus.
    J Virol. 2015 Oct 21. pii: JVI.02175.
    PubMed     Text format     Abstract available


  183. BATISHCHEV OV, Shilova LA, Kachala MV, Tashkin VY, et al
    pH-Dependent Formation and Disintegration of the Influenza A Virus Protein Scaffold to Provide Tension for Membrane Fusion.
    J Virol. 2015 Oct 14. pii: JVI.01539.
    PubMed     Text format     Abstract available


  184. BRAZZOLI M, Magini D, Bonci A, Buccato S, et al
    Induction of broad-based immunity and protective efficacy by self-amplifying mRNA vaccines encoding influenza virus hemagglutinin.
    J Virol. 2015 Oct 14. pii: JVI.01786.
    PubMed     Text format     Abstract available


  185. NG WC, Londrigan SL, Nasr N, Cunningham AL, et al
    The C-type lectin langerin functions as a receptor for attachment and infectious entry of influenza A virus.
    J Virol. 2015 Oct 14. pii: JVI.01447.
    PubMed     Text format     Abstract available


  186. DEVENTHIRAN J, Kumar SR, Raghunath S, Elankumaran S, et al
    PB1-F2 Protein does not impact the Virulence of Triple Reassortant H3N2 Swine Influenza Virus in Pigs but Alters the Pathogenicity and Transmission in Turkeys.
    J Virol. 2015 Oct 14. pii: JVI.01551.
    PubMed     Text format     Abstract available


  187. BLYTH GA, Chan WF, Webster RG, Magor KE, et al
    Duck IFITM3 mediates restriction of influenza viruses.
    J Virol. 2015 Oct 14. pii: JVI.01593.
    PubMed     Text format     Abstract available


  188. JIANG L, Fantoni G, Couzens L, Gao J, et al
    Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase.
    J Virol. 2015 Oct 14. pii: JVI.01756.
    PubMed     Text format     Abstract available


  189. CHO KJ, Schepens B, Moonens K, Deng L, et al
    Crystal structure of the conserved amino-terminus of the extracellular domain of matrix protein 2 of influenza A virus gripped by an antibody.
    J Virol. 2015 Oct 14. pii: JVI.02105.
    PubMed     Text format     Abstract available


  190. REN Y, Li C, Feng L, Pan W, et al
    Proton channel activity of influenza A virus matrix protein 2 contributes to autophagy arrest.
    J Virol. 2015 Oct 14. pii: JVI.00576.
    PubMed     Text format     Abstract available


  191. ANCHISI S, Guerra J, Mottet-Osman G, Garcin D, et al
    Mismatches in Influenza A virus vRNA panhandle prevent RIG-I sensing by impairing RNA/RIG-I complex formation.
    J Virol. 2015 Oct 7. pii: JVI.01671.
    PubMed     Text format     Abstract available


  192. DHAR J, Cuevas RA, Goswami R, Zhu J, et al
    2'-5'-Oligoadenylate Synthetase-Like Protein Inhibits Respiratory Syncytial Virus Replication and Is Targeted by the Viral Nonstructural Protein 1.
    J Virol. 2015;89:10115-9.
    PubMed     Text format     Abstract available


    September 2015
  193. TSURUDOME M, Ito M, Ohtsuka J, Hara K, et al
    The fusion protein specificity of the parainfluenza virus hemagglutinin-neuraminidase protein is not solely defined by the primary structure of its stalk domain.
    J Virol. 2015 Sep 30. pii: JVI.01448.
    PubMed     Text format     Abstract available


  194. LONDRIGAN SL, Short KR, Ma J, Gillespie L, et al
    Infection of mouse macrophages by seasonal influenza viruses can be restricted at the level of virus entry and at late stage in the virus life cycle.
    J Virol. 2015 Sep 30. pii: JVI.01455.
    PubMed     Text format     Abstract available


  195. FULTON BO, Palese P, Heaton NS
    Replication competent influenza B reporter viruses as tools for screening antivirals and antibodies.
    J Virol. 2015 Sep 23. pii: JVI.02164.
    PubMed     Text format     Abstract available


  196. TRAVANTY E, Zhou B, Zhang H, Di YP, et al
    Differential susceptibility of human lung primary cells to H1N1 influenza viruses.
    J Virol. 2015 Sep 16. pii: JVI.01792.
    PubMed     Text format     Abstract available


  197. VAN POUCKE S, Doedt J, Baumann J, Qiu Y, et al
    Role of Substitutions in the Hemagglutinin in the Emergence of the 1968 Pandemic Influenza Virus.
    J Virol. 2015 Sep 16. pii: JVI.01292.
    PubMed     Text format     Abstract available


  198. YANG Y, Zengel J, Sun M, Sleeman K, et al
    Regulation Of Viral RNA Synthesis By The V Protein Of Parainfluenza Virus 5.
    J Virol. 2015 Sep 16. pii: JVI.01832.
    PubMed     Text format     Abstract available


  199. SREENIVASAN C, Thomas M, Sheng Z, Hause BM, et al
    Replication and transmission of novel bovine influenza D virus in guinea pig model.
    J Virol. 2015 Sep 16. pii: JVI.01630.
    PubMed     Text format     Abstract available


  200. MAKELA SM, Osterlund P, Westenius V, Latvala S, et al
    RIG-I Signaling Is Essential For Influenza B Virus-Induced Rapid Interferon Gene Expression.
    J Virol. 2015 Sep 16. pii: JVI.01576.
    PubMed     Text format     Abstract available


  201. KIM KH, Lee YT, Hwang HS, Kwon YM, et al
    Virus-like particle vaccine containing the F protein of respiratory syncytial virus confers protection without pulmonary disease by modulating specific subsets of dendritic cells and effector T cells.
    J Virol. 2015 Sep 9. pii: JVI.02018.
    PubMed     Text format     Abstract available


  202. VERHAGEN JH, Hofle U, van Amerongen G, van de Bildt M, et al
    Long-term effect of serial infections with H13 and H16 low pathogenic avian influenza viruses in black-headed gulls.
    J Virol. 2015 Sep 2. pii: JVI.01765.
    PubMed     Text format     Abstract available


  203. ZHAO D, Fukuyama S, Yamada S, Lopes TJ, et al
    Molecular determinants of virulence and stability of a reporter-expressing H5N1 influenza A virus.
    J Virol. 2015 Sep 2. pii: JVI.01886.
    PubMed     Text format     Abstract available


    August 2015
  204. RAJAO DS, Gauger PC, Anderson TK, Lewis NS, et al
    Novel reassortant human-like H3N2 and H3N1 influenza A viruses detected in pigs are virulent and antigenically distinct from endemic viruses.
    J Virol. 2015 Aug 26. pii: JVI.01675.
    PubMed     Text format     Abstract available


  205. SOLORZANO A, Foni E, Cordoba L, Baratelli M, et al
    Cross-species infectivity of H3N8 influenza virus in an experimental infection in swine.
    J Virol. 2015 Aug 26. pii: JVI.01509.
    PubMed     Text format     Abstract available


  206. REJMANEK D, Hosseini PR, Mazet JA, Daszak P, et al
    Evolutionary dynamics and global diversity of influenza A virus.
    J Virol. 2015 Aug 26. pii: JVI.01573.
    PubMed     Text format     Abstract available


  207. MACHKOVECH HM, Bedford T, Suchard MA, Bloom JD, et al
    Positive selection in CD8+ T-cell epitopes of influenza nucleoprotein revealed by a comparative analysis of human and swine viral lineages.
    J Virol. 2015 Aug 26. pii: JVI.01571.
    PubMed     Text format     Abstract available


  208. SU WC, Hsu SF, Lee YY, Jeng KS, et al
    A Nucleolar Protein, Ribosomal RNA Processing 1 Homolog B (RRP1B), Enhances the Recruitment of Cellular mRNA in Influenza Virus Transcription.
    J Virol. 2015 Aug 26. pii: JVI.01487.
    PubMed     Text format     Abstract available


  209. SONG MS, Marathe BM, Kumar G, Wong SS, et al
    Unique determinants of neuraminidase inhibitor resistance among N3, N7, and N9 avian influenza viruses.
    J Virol. 2015 Aug 19. pii: JVI.01514.
    PubMed     Text format     Abstract available


  210. VERHELST J, Spitaels J, Nurnberger C, De Vlieger D, et al
    Functional comparison of Mx1 from two different mouse species reveals the involvement of loop L4 in the antiviral activity against influenza A viruses.
    J Virol. 2015 Aug 19. pii: JVI.01744.
    PubMed     Text format     Abstract available


  211. BELJANSKI V, Chiang C, Kirchenbaum GA, Olagnier D, et al
    Enhanced influenza VLP vaccination with a structurally optimized RIG-I agonist as adjuvant.
    J Virol. 2015 Aug 12. pii: JVI.01526.
    PubMed     Text format     Abstract available


  212. FAN RL, Valkenburg SA, Wong CK, Li OT, et al
    Generation of live attenuated influenza virus using codon usage bias.
    J Virol. 2015 Aug 12. pii: JVI.01443.
    PubMed     Text format     Abstract available


  213. WANG W, DeFeo CJ, Alvarado E, Vassell R, et al
    Intermonomer Interactions in Hemagglutinin subunits HA1 and HA2 Affecting Hemagglutinin Stability and Influenza Virus Infectivity.
    J Virol. 2015 Aug 12. pii: JVI.00939.
    PubMed     Text format     Abstract available


  214. DIEDERICH S, Berhane Y, Embury-Hyatt C, Hisanaga T, et al
    Hemagglutinin-Neuraminidase Balance Influences the Virulence Phenotype of a Recombinant H5N3 Influenza A Virus Possessing a Polybasic HA0 Cleavage Site.
    J Virol. 2015 Aug 5. pii: JVI.01238.
    PubMed     Text format     Abstract available


  215. JU X, Yan Y, Liu Q, Li N, et al
    Neuraminidase of influenza A virus binds LAMPs directly and induces lysosome rupture.
    J Virol. 2015 Aug 5. pii: JVI.01411.
    PubMed     Text format     Abstract available


  216. TURKINGTON HL, Juozapaitis M, Kerry PS, Aydillo T, et al
    Novel Bat Influenza Virus NS1 Proteins Bind Double-Stranded RNA and Antagonize Host Innate Immunity.
    J Virol. 2015 Aug 5. pii: JVI.01430.
    PubMed     Text format     Abstract available


  217. GUO X, Liu T, Shi H, Wang J, et al
    Respiratory Syncytial Virus Infection Upregulates NLRC5 and Major Histocompatibility Complex Class I Expression through RIG-I Induction in Airway Epithelial Cells.
    J Virol. 2015;89:7636-45.
    PubMed     Text format     Abstract available


  218. TRENTO A, Abrego L, Rodriguez-Fernandez R, Gonzalez-Sanchez MI, et al
    Conservation of G-Protein Epitopes in Respiratory Syncytial Virus (Group A) Despite Broad Genetic Diversity: Is Antibody Selection Involved in Virus Evolution?
    J Virol. 2015;89:7776-85.
    PubMed     Text format     Abstract available


  219. NOTON SL, Nagendra K, Dunn EF, Mawhorter ME, et al
    Respiratory Syncytial Virus Inhibitor AZ-27 Differentially Inhibits Different Polymerase Activities at the Promoter.
    J Virol. 2015;89:7786-98.
    PubMed     Text format     Abstract available


    July 2015
  220. HARTMANN BM, Thakar J, Albrecht RA, Avey S, et al
    Human dendritic cell response signatures distinguish 1918, pandemic and seasonal H1N1 influenza viruses.
    J Virol. 2015 Jul 29. pii: JVI.01523.
    PubMed     Text format     Abstract available


  221. PULIT-PENALOZA JA, Sun X, Creager HM, Zeng H, et al
    Pathogenesis and transmission of novel HPAI H5N2 and H5N8 avian influenza viruses in ferrets and mice.
    J Virol. 2015 Jul 29. pii: JVI.01438.
    PubMed     Text format     Abstract available


  222. ZHENG M, Wang P, Song W, Lau SY, et al
    A14U Substitution in 3' Non-Coding Region of M vRNA Supports Replication of NS1-Deleted Influenza Virus by Modulating Alternative Splicing of M mRNAs.
    J Virol. 2015 Jul 29. pii: JVI.00919.
    PubMed     Text format     Abstract available


  223. MACKOW N, Amaro Carambot E, Liang B, Surman S, et al
    Attenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion F Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine.
    J Virol. 2015 Jul 29. pii: JVI.01380.
    PubMed     Text format     Abstract available


  224. WATSON SJ, Langat P, Reid SM, Lam TT, et al
    Molecular Epidemiology and Evolution of Influenza Viruses Circulating within European Swine between 2009 and 2013.
    J Virol. 2015 Jul 22. pii: JVI.00840.
    PubMed     Text format     Abstract available


  225. LUK GS, Leung CY, Sia SF, Choy KT, et al
    Transmission of H7N9 influenza viruses with polymorphism at PB2 residue 627 in chickens and ferrets.
    J Virol. 2015 Jul 22. pii: JVI.01444.
    PubMed     Text format     Abstract available


  226. SHIN DL, Hatesuer B, Bergmann S, Nedelko T, et al
    Protection from severe influenza infections in mice carrying the Mx1 influenza resistance gene strongly depends on genetic background.
    J Virol. 2015 Jul 22. pii: JVI.01305.
    PubMed     Text format     Abstract available


  227. VER LS, Marcos-Villar L, Landeras-Bueno S, Nieto A, et al
    The cellular factor NXP2/MORC3 is a positive regulator for influenza virus multiplication.
    J Virol. 2015 Jul 22. pii: JVI.01530.
    PubMed     Text format     Abstract available


  228. LIANG B, Surman S, Amaro-Carambot E, Kabatova B, et al
    Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Pre-fusion F Protein Expressed by a Vaccine Candidate.
    J Virol. 2015 Jul 8. pii: JVI.01373.
    PubMed     Text format     Abstract available


  229. SAM IC, Su YC, Chan YF, Nor'E SS, et al
    Evolution of influenza B virus in Kuala Lumpur, Malaysia between 1995 and 2008.
    J Virol. 2015 Jul 1. pii: JVI.00708.
    PubMed     Text format     Abstract available


    June 2015
  230. GNIRSS K, Zmora P, Blazejewska P, Winkler M, et al
    Tetherin sensitivity of influenza A viruses is strain specific: Role of hemagglutinin and neuraminidase.
    J Virol. 2015 Jun 24. pii: JVI.00615.
    PubMed     Text format     Abstract available


  231. RESA-INFANTE P, Paterson D, Bonet J, Otte A, et al
    Targeting importin-alpha7 as a therapeutic approach against pandemic influenza viruses.
    J Virol. 2015 Jun 17. pii: JVI.00583.
    PubMed     Text format     Abstract available


  232. CHLANDA P, Schraidt O, Kummer S, Riches J, et al
    Structural analysis of the roles of influenza A virus membrane-associated proteins in assembly and morphology.
    J Virol. 2015 Jun 17. pii: JVI.00592.
    PubMed     Text format     Abstract available


  233. YU Y, Wang X, Jin T, Wang H, et al
    Newly-emergent highly pathogenic H5N9 subtype avian influenza A virus.
    J Virol. 2015 Jun 17. pii: JVI.00653.
    PubMed     Text format     Abstract available


  234. WANG J, Chen Z, Bao L, Zhang W, et al
    Characterization of Two Human Monoclonal Antibodies Neutralizing Influenza A H7N9 Viruses.
    J Virol. 2015 Jun 10. pii: JVI.01295.
    PubMed     Text format     Abstract available


  235. CAMP JV, Bagci U, Chu YK, Squier B, et al
    Lower Respiratory Tract Infection of the Ferret by 2009 H1N1 Pandemic Influenza A Virus Triggers Biphasic, Systemic and Local Neutrophil Recruitment.
    J Virol. 2015 Jun 10. pii: JVI.00817.
    PubMed     Text format     Abstract available


  236. SU S, Bi Y, Wong G, Gray GC, et al
    The epidemiology, evolution and recent outbreaks of avian influenza viruses in China: A Review.
    J Virol. 2015 Jun 10. pii: JVI.01034.
    PubMed     Text format     Abstract available


  237. OISHI K, Yamayoshi S, Kawaoka Y
    Mapping of a region of the PA-X protein of influenza A virus that is important for its shut-off activity.
    J Virol. 2015 Jun 3. pii: JVI.01132.
    PubMed     Text format     Abstract available


  238. TAO H, Li L, White MC, Steel J, et al
    Influenza A virus co-infection through transmission can support high levels of reassortment.
    J Virol. 2015 Jun 3. pii: JVI.01162.
    PubMed     Text format     Abstract available


    May 2015
  239. HAYASHI T, Wills S, Bussey KA, Takimoto T, et al
    Identification of influenza A virus PB2 residues involved in enhanced polymerase activity and virus growth in mammalian cells at low temperature.
    J Virol. 2015 May 27. pii: JVI.00901.
    PubMed     Text format     Abstract available


  240. SONG Y, Wang X, Zhang H, Tang X, et al
    Repeated Low-dose Influenza Virus Infection Causes Severe Disease in Mice: a Model for Vaccine Evaluation.
    J Virol. 2015 May 20. pii: JVI.00976.
    PubMed     Text format     Abstract available


  241. DLUGOLENSKI D, Jones L, Howerth E, Wentworth D, et al
    Swine Influenza Virus PA and Neuraminidase Gene Reassortment into Human H1N1 Influenza Virus Is Associated with an Altered Pathogenic Phenotype Linked to Increased MIP-2 Expression.
    J Virol. 2015;89:5651-67.
    PubMed     Text format     Abstract available


  242. LI H, Ma Y, Escaffre O, Ivanciuc T, et al
    Role of hydrogen sulfide in paramyxovirus infections.
    J Virol. 2015;89:5557-68.
    PubMed     Text format     Abstract available


    April 2015
  243. ZENG H, Belser JA, Goldsmith CS, Gustin KM, et al
    A(H7N9) virus results in early induction of proinflammatory cytokine responses in both human lung epithelial and endothelial cells and shows increased human adaptation compared with avian H5N1 virus.
    J Virol. 2015;89:4655-67.
    PubMed     Text format     Abstract available


  244. SCHIBLER M, Piuz I, Hao W, Tapparel C, et al
    Chimeric rhinoviruses obtained via genetic engineering or artificially induced recombination are viable only if the polyprotein coding sequence derives from the same species.
    J Virol. 2015;89:4470-80.
    PubMed     Text format     Abstract available


  245. AGOTI CN, Otieno JR, Munywoki PK, Mwihuri AG, et al
    Local evolutionary patterns of human respiratory syncytial virus derived from whole-genome sequencing.
    J Virol. 2015;89:3444-54.
    PubMed     Text format     Abstract available


  246. KOEL BF, Mogling R, Chutinimitkul S, Fraaij PL, et al
    Identification of amino acid substitutions supporting antigenic change of influenza A(H1N1)pdm09 viruses.
    J Virol. 2015;89:3763-75.
    PubMed     Text format     Abstract available


  247. TAN Y, Ng Q, Jia Q, Kwang J, et al
    A novel humanized antibody neutralizes H5N1 influenza virus via two different mechanisms.
    J Virol. 2015;89:3712-22.
    PubMed     Text format     Abstract available


    February 2015
  248. VAN DIEPEN A, Brand HK, de Waal L, Bijl M, et al
    Host Proteome Correlates of Vaccine-Mediated Enhanced Disease in a Mouse Model of Respiratory Syncytial Virus Infection.
    J Virol. 2015 Feb 18. pii: JVI.03630.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: